DocGo Inc. 8-K

What Happened
DocGo Inc. (DCGO) filed an 8-K reporting the results of its 2026 Annual Meeting of Stockholders held June 16, 2026 (record date April 20, 2026; 98,778,413 shares entitled to vote). Two Class II director nominees, Vina Leite and James M. Travers, were elected to serve until the 2029 Annual Meeting. Stockholders approved, on an amendment to the charter, a reverse stock split authorization (1-for-5 up to 1-for-10, to be set by the Board). Stockholders did not approve two proposed charter amendments (corporate opportunity waiver and officer exculpation). The appointment of Urish Popeck & Co., LLC as independent registered public accounting firm for 2026 was ratified. The filing was signed June 18, 2026 by Ely D. Tendler.

Key Details

• Record date and voting power: 98,778,413 shares entitled to vote as of April 20, 2026.
• Director elections: Vina Leite — For 31,241,093; Withheld 18,924,442; Broker non-votes 21,849,313. James M. Travers — For 25,062,607; Withheld 25,102,928; Broker non-votes 21,849,313.
• Say-on-pay (advisory): For 39,768,972; Against 10,213,238; Abstentions 183,325; Broker non-votes 21,849,313 (advisory approval).
• Reverse stock split authorization: For 66,141,612; Against 5,673,628; Abstentions 199,608 — stockholders approved board authority to effect a 1-for-5 to 1-for-10 reverse split.
• Failed charter amendments: Corporate Opportunity Amendment — For 40,810,518; Against 8,726,933; Abstentions 628,084; Officer Exculpation Amendment — For 43,427,921; Against 5,990,544; Abstentions 747,070 (neither received requisite votes to amend the charter).
• Auditor ratification: Urish Popeck & Co., LLC ratified as independent registered public accounting firm for year ending Dec 31, 2026 (For 67,639,242; Against 3,874,903; Abstentions 500,703).

Why It Matters
The meeting confirmed board composition (two Class II directors elected) and gave the Board the explicit authority to implement a reverse stock split at ratios between 1-for-5 and 1-for-10, which, if and when implemented, would proportionally reduce outstanding shares and increase per‑share outstanding share price. Shareholder approval of the company’s executive compensation (non‑binding) and ratification of the auditor remove immediate governance uncertainties on those items. The failed charter amendments mean no change to the company’s current corporate opportunity and officer liability provisions. Investors should note the detailed vote totals (including significant broker non-votes on some matters) when assessing shareholder support levels.